Dietary Management of Heart Failure: DASH Diet and Precision Nutrition Perspectives

Authors, Journal, Affiliations, Type, DOI

• Brooke E. Wickman, Byambaa Enkhmaa, Ronit Ridberg, Erick Romero, Martin Cadeiras, Frederick Meyers, Francene Steinberg
• Nutrients 2021, 13(12), 4424
• Graduate Group in Nutritional Biology + Center for Precision Medicine + Division of Cardiovascular Medicine, University of California Davis
• Review article (narrative)
• DOI: https://doi.org/10.3390/nu13124424

Overview

A narrative review from UC Davis synthesizing evidence for using the Dietary Approaches to Stop Hypertension (DASH) diet in outpatient heart failure management. The authors argue that current HF dietary care — focused narrowly on sodium and fluid restriction — is insufficient, and that the DASH diet offers a promising comprehensive dietary strategy with anti-inflammatory, antihypertensive, and micronutrient-repletion mechanisms. A controlled feeding study demonstrated DASH + sodium restriction reduces cardiac injury biomarkers (hs-cTnI −20%) and cardiac strain (NT-proBNP −23%) vs control in hypertensive patients. The review proposes a precision nutrition framework integrating genomics, metabolomics, and gut microbiome data to individualize dietary HF care — but acknowledges that no large pragmatic RCT has yet been conducted specifically in diagnosed HF patients.

Keywords

Heart failure; dietary approaches to stop hypertension; DASH diet; diet pattern; metabolism; metabolomics; precision nutrition; personalized nutrition

Key Takeaways

Heart Failure Overview

• HF affects ~6.2 million US adults and >26 million worldwide; prevalence continues to rise with population aging; economic burden $30.7 billion in the US in 2012 (80% from hospitalizations)
• Classified into four stages: A (at risk), B (pre-HF, asymptomatic structural disease), C (symptomatic), D (advanced/end-stage)
• EF-based classification: HFrEF, HFmrEF, HFpEF — overlapping phenotypes with intertwined pathophysiology; HFrEF responds well to standardized treatment while HFpEF remains less tractable
• Co-morbid risk factors: smoking, hypertension, obesity, T2DM/insulin resistance, ischemic heart disease

Current Dietary Recommendations for HF

• Primary dietary approaches remain sodium restriction (2–3 g/d — guideline recommendation based on Level C evidence only) and fluid restriction (1.5–2 L/day for Stage D or severe hyponatremia per ACC/AHA)
• A recent systematic review found no robust evidence favoring any specific sodium restriction level between 1.5–3 g/d; overly strict restriction (1.5 g/d) can cause reduced palatability, nutritional deficiencies, and paradoxically increased thirst
• ESC guidelines recommend avoiding >5 g salt/day and healthy diet to prevent malnutrition — no comprehensive HF-specific diet plan at a guideline level
• Beyond sodium/fluid, no cardiology society provides comprehensive dietary guidelines for HF; significant gap remains

Body Weight in HF

• Excess body weight → neurohormonal cardiac remodeling → increased HF risk; weight reduction improves cardiac function and reduces HF hospitalizations in overweight/obese patients with Stage C HF
• U-shaped BMI–mortality relationship in HF: some excess weight is most protective in females with advanced HF (Stages C–D); cardiac cachexia indicates end-stage disease
• Underweight status and sarcopenia are independently prognostic of adverse outcomes even after controlling for confounders

Dietary Patterns and DASH Diet

• Various healthy eating indices (HEI-2015, AHEI, HPDI, AMED) are consistently and inversely associated with CVD risk in large prospective populations
• Mediterranean and DASH diets share core features (fruits, vegetables, whole grains, legumes, nuts); DASH appears more consistently beneficial for HF prevention vs Mediterranean
• Mediterranean diet did not significantly reduce HF incidence in one large-scale RCT (study may have been underpowered)
• DASH diet composition: whole grains, fruits, vegetables, low-fat dairy, lean meat/fish/poultry, nuts, seeds, legumes; sparse fats and oils; high in potassium, magnesium, calcium, nitrates, antioxidants, and fiber; low in saturated and trans fats

Sodium Restriction and DASH Combined

• DASH–Sodium trial: DASH + sodium 1500 mg/d vs control + 3450 mg/d sodium reduced SBP by 7.1 mmHg in normotensive and 11.5 mmHg in hypertensive participants
• DASH alone reduced SBP 5.5 mmHg / DBP 3.0 mmHg vs control (original Appel et al. NEJM 1997 study)
• DASH + modest sodium restriction (vs DASH alone) decreased hs-cTnI by 20% and NT-proBNP by 23% — two distinct cardioprotective pathways: DASH reducing cardiac injury, sodium reduction reducing cardiac strain; derived from original DASH trial population with untreated hypertension, not diagnosed HF

DASH Diet Mechanisms in HF

• Beneficial across multiple pathways: BP reduction, reduced pro-inflammatory cytokines and reactive oxygen species, improved endothelial function, restored micronutrient status, arterial compliance improvement, and quality of life improvement
• High potassium + low sodium combination reduces BP; high magnesium, calcium, nitrates, and antioxidants contribute to cardiovascular health
• DASH adherence associated with improved cardiac function assessed by end-diastolic volume and stroke volume (MESA study data)
• Three-week DASH + sodium-restricted diet in HFpEF patients: significant reductions in BP and arterial stiffness, improved ventricular diastolic function, reduced oxidative stress (small pilot study)
• GOURMET-HF study: home-delivered DASH meals post-discharge reduced HF symptoms, physical limitations, and hospitalizations
• 6-month randomized intervention in symptomatic HF: DASH significantly improved exercise capacity and quality of life vs usual care

Nutritional Supplements in HF

• Antioxidant vitamins (C, E) largely ineffective in clinical trials
• CoQ10: Q-SYMBIO trial showed lower CV mortality, all-cause mortality, HF hospitalizations vs placebo in moderate-to-severe HF; two meta-analyses improved LV function, another showed no difference — inconsistent evidence
• Omega-3 (marine): meta-analysis of 12 RCTs showed significant reduction in recurrent HF hospitalizations vs placebo; no effect on CV mortality; conflicting across trials
• IV ferric carboxymaltose reduced recurrent HF hospitalizations (large multicenter RCT); oral iron supplementation not included in guidelines absent iron deficiency anemia

Metabolomics and DASH Diet

• Seven controlled DASH feeding trials have characterized diet-responsive metabolites in blood and urine biosamples
• Original DASH trial: 44 significantly different metabolites vs control; 10-metabolite candidate panel as biomarkers for DASH adherence (lipids, amino acids, xenobiotics, carbohydrates)
• HFpEF controlled feeding study: short-chain acyl carnitine metabolites (L-carnitine, propionyl carnitine) increased and correlated with improved LV contractility, inversely with ventricular stiffness
• Gut-derived TMAO is elevated in HF and associated with acute and long-term adverse outcomes
• Food-specific compounds detectable in urine after DASH intervention (apples, blueberries, broccoli, etc.); metabolomics can track dietary adherence objectively
• Gap: no studies using metabolomics to characterize DASH adherence in free-living HF patients

Behavioral and Implementation Science

• Self-efficacy is central to sustained dietary behavior change; CBT and motivational interviewing improve HF self-care
• PREMIER and ENCORE trials demonstrated significantly increased DASH-specific food consumption vs advice-only group via intensive counseling (weekly to monthly, 4–18 months)
• Poor sodium adherence in HF is well-documented; additional rationale for comprehensive dietary approach over single-nutrient restriction
• Telehealth dietary coaching: effective in CKD (Stages 3–4) but limited evidence in HF; trials underway
• Implementation science estimates 17 years from evidence to clinical practice — structured implementation approaches needed

Precision Nutrition Framework

• Precision nutrition = individualized nutritional guidance based on genomic, metabolomic, proteomic, and metagenomic profiling; NIH Nutrition for Precision Health Strategic Plan 2021–2025 priority
• Single nucleotide polymorphisms affect nutritional needs and metabolic responses to diet
• Microbiome-derived metabolites (short-chain fatty acids, bile acids, TMAO, amino acid metabolites) are affected by diet and can be assessed for risk stratification in HF
• HFpEF phenotyping has potential to identify subgroups most likely to respond to DASH diet; HFrEF vs HFpEF response to DASH diet in REGARDS cohort was not statistically different

Limitations of the Document

• Narrative review, not systematic — subject to selection bias in literature coverage
• Most HF-specific DASH interventions have small sample sizes (n=13–20), single-arm designs, and short durations (3 weeks to 6 months)
• Key controlled feeding data (DASH–Sodium hs-cTnI/NT-proBNP reductions) derived from hypertensive patients without diagnosed CVD — extrapolation to HF patients uncertain
• No large pragmatic RCT of DASH diet in diagnosed HF patients has been conducted; evidence base for definitive guideline recommendation is absent
• Mediterranean diet RCT data may have been underpowered for HF incidence outcomes
• Precision nutrition framework is largely aspirational; metabolomic HF-DASH studies are small and preliminary

Key Concepts Mentioned

• concepts/Heart-Healthy-Dietary-Patterns — DASH diet as a named compliant pattern; comparison with Mediterranean diet; sodium and potassium mechanisms
• concepts/Gut-Microbiome-in-HF — TMAO as adverse HF biomarker; dietary modulation of gut microbiome in HF
• concepts/CAM-in-Heart-Failure — omega-3, CoQ10, and iron supplementation evidence in HF
• concepts/Iron-Deficiency-in-HF — IV ferric carboxymaltose reducing recurrent HF hospitalizations
• concepts/Cardiac-Rehabilitation-HF — exercise capacity improvements with DASH diet comparable to rehabilitation goals

Key Entities Mentioned

• entities/HFpEF — specific DASH diet benefit in hypertensive HFpEF; metabolomic changes in HFpEF pilot study
• entities/Heart-Failure — central disease context throughout

Wiki Pages Updated

• wiki/sources/dash-nutrients-2021.md — created (this file)
• wiki/concepts/Heart-Healthy-Dietary-Patterns.md — added DASH-in-HF section and new contradiction
• wiki/concepts/Gut-Microbiome-in-HF.md — added TMAO/DASH dietary modification content
• wiki/sourceindex.md — added entry
• wiki/wikiindex.md — updated Heart-Healthy-Dietary-Patterns description